GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. uri icon

authors

  • Cruchaga, Carlos
  • Carrell, David
  • Bertelsen, Sarah
  • Bailey, Matthew
  • McKean, David
  • Shulman, Joshua M
  • De Jager, Philip L
  • Chibnik, Lori
  • Bennett, David A
  • Arnold, Steve E
  • Harold, Denise
  • Kauwe, John S K
  • Sims, Rebecca
  • Gerrish, Amy
  • Williams, Julie
  • Van Deerlin, Vivianna M
  • Lee, Virginia M-Y
  • Shaw, Leslie M
  • Trojanowski, John Q
  • Haines, Jonathan L
  • Mayeux, Richard
  • Pericak-Vance, Margaret A
  • Harari, Oscar
  • Farrer, Lindsay A
  • Schellenberg, Gerard D
  • Peskind, Elaine R
  • Galasko, Douglas
  • Fagan, Anne M
  • David M. Holtzman, MD
  • Morris, John C
  • Jin, Sheng Chih
  • Goate, Alison M
  • Cai, Yefei
  • Karch, Celeste M
  • Benitez, Bruno A
  • Jeng, Amanda T
  • Skorupa, Tara

publication date

  • January 1, 2013

published in